ACTH inhibits A Ras-dependent anti-apoptotic and mitogenic pathway in mouse Y1 adrenocortical cells

F L Forti1, H A Armelin

  • 1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brasil.

Endocrine Research
|February 24, 2001
PubMed

Insights

Mouse Y1 tumor cells show high Ras x GTP, leading to increased AKT/PKB phosphorylation. Adrenocorticotropic hormone (ACTH) inhibits this pathway, suggesting a role in ACTH-mediated growth inhibition.

Area of Science:

  • Cell biology
  • Molecular endocrinology
  • Oncology

Background:

  • Mouse Y1 adrenocortical tumor cells exhibit c-Ki-ras gene amplification and overexpression.
  • These cells display high constitutive levels of Ras x GTP, a key signaling molecule.

Purpose of the Study:

  • To investigate the role of Ras x GTP and phosphoinositide 3-kinase (PI3K) in regulating AKT/protein kinase B (PKB) phosphorylation in Y1 cells.
  • To determine the effect of adrenocorticotropic hormone (ACTH) on AKT/PKB signaling in these cells.

Main Methods:

  • Analysis of Ras x GTP levels.
  • Assessment of AKT/PKB phosphorylation status.
  • Investigation of signaling pathways involving PI3K, cyclic adenosine monophosphate (cAMP), and protein kinase A (PKA).

Main Results:

  • Y1 cells constitutively display high levels of phosphorylated AKT/PKB, dependent on Ras x GTP and PI3K.
  • ACTH rapidly induces dephosphorylation of AKT/PKB in a cAMP/PKA-dependent manner.
  • This ACTH-induced inhibition affects both anti-apoptotic and mitogenic signaling.

Conclusions:

  • The Ras/PI3K pathway is crucial for constitutive AKT/PKB activation in Y1 adrenocortical tumor cells.
  • ACTH-mediated inhibition of the AKT/PKB pathway is a significant mechanism underlying its growth-inhibitory effects on Y1 cells.
  • These findings highlight the complex interplay between oncogenic signaling and hormonal regulation in adrenocortical tumorigenesis.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...